|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Surgical treatment of aneurysms of the transverse aortic arch,experience with 25 patients using hypothermic technique显示文摘 | Cooley DA Ott DA Frasier OH | 1981 | Ann Thorac Surg1981，32，3： | 1 |
| 2 | Amino acid composition of the fetal pig 显示文摘 | Wu G Ott TL Knabe DA | 1999 | J Nutr1999，129，5： | 1 |
| 3 | A synthesis of progesterone from ergosterol显示文摘 | Shepherd DA Donia RA Ott AC | 1955 | JAmer Chem Soc1955，77，： | 1 |
| 4 | Primary cardiac tumors in infants and children:immediate and long-term operative results显示文摘 | Reul GJ Ott DA | 1996 | Ann Thorac Surg1996，62，2： | 1 |
| 5 | Primary cardiac tumors in infants and children:immediate and long-term operative results显示文摘 | Takach TJ Reul GJ Ott DA | 1996 | Ann Thorac Strg1996，62，2： | 1 |
| 6 | Surgical management of 56 patients with congenital coronary artery fistulas显示文摘 | Urrutia-S CO Falaschi G Ott DA | 1983 | Ann Thorac Surg1983，35，3： | 1 |
| 7 | Surgical management of 56 patients with congenital coronary artery tistulas 显示文摘 | Urrutia SCO Falaschi G Ott DA Cooleq DA | 1983 | Ann Thorac Surg1983，35，： | 1 |
| 8 | Aneurysm of the sinus of valsalva显示文摘 | Ott DA | 2006 | Semin Thorac Cardiovasc Surg Pediatr Card Surg Ann2006，，： | 1 |
| 9 | Circulating endothelial progenitor cells显示文摘 | OTT HC TAYLOR DA | 2005 | N Engl J Med2005，353，24： | 1 |
| 10 | Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart 显示文摘 | Ott HC Taylor DA Thomas SM | 2008 | Nature Med2008，14，2： | 1 |
| 11 | Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease 显示文摘 | Cahn-Weiner DA Grace J Ott BR | 2002 | Neuropsyehiatry Neuropsyebol Behav Neurol2002，15，2： | 1 |
| 12 | Reoperation for recurrent coronary artery disease:causes,indications,and results in 168 patients显示文摘 | Reul GL Jr Cooley DA Ott DA | 1979 | Arch Surg1979，114，： | 1 |
| 13 | Lung allografts in dogs treated with methotrexate and antilymphocyte serum显示文摘 | Blumenstock DA Otte HP Grosjean OV et al | 1968 | Ann Thorac Surg1968，6，1： | 1 |
| 14 | Anomalous origin of cir- cumflex coronary artery from right pulmonary artery : report of a rare anomaly 显示文摘 | Ott DA Cooley DA Pinsky WW | 1978 | J Thorac Cardiovase Surg1978，76，2： | 1 |
| 15 | Fecal microbiota transplantation in patients with metabolic syndrome and obesity:A randomized controlled trial显示文摘BACKGROUND Metabolic syndrome is a multifactorial disease,and the gut microbiota may play a role in its pathogenesis.Obesity,especially abdominal obesity,is associated with insulin resistance,often increasing the risk of type two diabetes mellitus,vascular endothelial dysfunction,an abnormal lipid profile,hypertension,and vascular inflammation,all of which promote the development of atherosclerotic cardiovascular disease.AIM To evaluate the outcomes of fecal microbiota transplantation(FMT)in patients with metabolic syndrome.METHODS This was a randomized,single-blind placebo-controlled trial comparing FMT and a sham procedure in patients with metabolic syndrome.We selected 32 female patients,who were divided into eight groups of four patients each.All of the patients were submitted to upper gastrointestinal endoscopy.In each group,two patients were randomly allocated to undergo FMT,and the other two patients received saline infusion.The patients were followed for one year after the procedures,during which time anthropometric,bioimpedance,and biochemical data were collected.The patients also had periodic consultations with a nutritionist and an endocrinologist.The primary end point was a change in the gut microbiota.RESULTS There was evidence of a postprocedural change in microbiota composition in the patients who underwent FMT in relation to that observed in those who underwent the sham procedure.However,we found no difference between the two groups in terms of the clinical parameters evaluated.CONCLUSION There were no significant differences in biochemical or anthropometric parameters,between the two groups evaluated.Nevertheless,there were significant postprocedural differences in the microbiota composition between the placebo group.To date,clinical outcomes related to FMT remain uncertain. | Alberto Machado da Ponte Neto Aniele Cristine Ott Clemente Paula Waki Rosa Igor Braga Ribeiro Mateus Pereira Funari Gabriel Cairo Nunes Luana Moreira Luiz Gustavo Sparvoli Ramon Cortez Carla Romano Taddei Márcio C Mancini Eduardo Guimarães Hourneaux de Moura | 2023 | World Journal of Clinical Cases2023，11，19： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员